Your session is about to expire
← Back to Search
Formula Diet Weight Loss for Obesity
N/A
Waitlist Available
Led By Allan Geliebter, PhD
Research Sponsored by New York Obesity and Nutrition Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
BMI range 35-50 kg/m^2
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 mo pre-surgery and 3 and 18 mo post-surgery
Awards & highlights
Study Summary
The investigators are looking at the differences in appetite and obesity between weight loss participants and patients undergoing bariatric surgery. Obese persons between the ages of 18 & 65 are eligible to participate in this study, whether or not they intend to undergo bariatric surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 mo pre-surgery and 3 and 18 mo post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 mo pre-surgery and 3 and 18 mo post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in brain activation in response to visual and auditory food cues
Secondary outcome measures
Anthropometrics and Body Composition
Change in appetite-related gut peptide levels
Eating Behavior
+1 moreTrial Design
5Treatment groups
Experimental Treatment
Group I: Sleeve Gastrectomy SurgeryExperimental Treatment2 Interventions
30 subjects who plan to undergo Sleeve Gastrectomy bariatric surgery. Liquid meal responses and Behavioral fMRI responses to food-cues will be assessed before surgery (T1), 3 months (T2) and 18 months (T3) after surgery.
Group II: Roux-en-Y Gastric BypassExperimental Treatment2 Interventions
30 subjects who plan to undergo Roux-en-Y Gastric Bypass bariatric surgery. Liquid meal responses and Behavioral fMRI responses to food-cues will be assessed before surgery (T1), 3 months (T2) and 18 months (T3) after surgery.
Group III: No TreatmentExperimental Treatment2 Interventions
30 subjects who do not undergo any treatment for weight loss. Liquid meal responses and Behavioral fMRI responses to food-cues will be assessed at baseline (T1) and at 3 months (T2) and 18 months (T3) later.
Group IV: Gastric Banding (Lap-band)Experimental Treatment2 Interventions
30 subjects who plan to undergo Gastric Banding bariatric surgery. Liquid meal responses and Behavioral fMRI responses to food-cues will be assessed before surgery (T1), 3 months (T2) and 18 months (T3) after surgery.
Group V: Formula Diet Weight LossExperimental Treatment2 Interventions
30 subjects who plan to begin a formula diet to lose weight. Liquid meal responses and Behavioral fMRI responses to food-cues will be assessed before subjects undertake a 12-week weight loss intervention (T1), at the end of the weight loss intervention (T2) and 18 months after they completed the weight loss intervention(T3).
Find a Location
Who is running the clinical trial?
St. Luke's-Roosevelt Hospital CenterOTHER
95 Previous Clinical Trials
18,176 Total Patients Enrolled
13 Trials studying Obesity
1,230 Patients Enrolled for Obesity
New York Obesity and Nutrition Research CenterLead Sponsor
7 Previous Clinical Trials
503 Total Patients Enrolled
5 Trials studying Obesity
399 Patients Enrolled for Obesity
Columbia UniversityOTHER
1,432 Previous Clinical Trials
2,460,813 Total Patients Enrolled
40 Trials studying Obesity
5,834 Patients Enrolled for Obesity
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger